Showing results (1-10 of 169) with videos related to
Sort By:
Pageof 17
ACS Omega|August 8, 2026
Improved 140Nd Production for the 140Nd/140Pr In Vivo Generator through Target Recycling and Radiochemical OptimizationMangi Lal Godara, Gabriel Dufour, Anna Buryachenko, et al.Scientific Reports|October 7, 2025
Production and radiochemistry of the in vivo PET generator 140Nd/140Pr as an imaging surrogate for F-block therapeutic radionuclidesMangi Lal Godara, Shelbie J Cingoranelli, Volkan Tekin, et al.Molecular Imaging|September 22, 2020
Peptide Based Imaging Agents for HER2 Imaging in OncologyMaxwell Ducharme, Suzanne E LapiPharmaceuticals (Basel, Switzerland)|April 27, 2024
Titanium-45 (45Ti) Radiochemistry and Applications in Molecular ImagingShefali Saini, Suzanne E LapiCancers|April 30, 2021
Positron Emission Tomography Imaging of Macrophages in CancerCandace C Parker, Suzanne E LapiJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
Production and Use of the First-Row Transition Metal PET Radionuclides 43,44Sc, 52Mn, and 45TiIvis F Chaple, Suzanne E LapiFuture Medicinal Chemistry|April 30, 2011
The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86Oluwatayo F Ikotun, Suzanne E LapiJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2013
Designing the magic bullet? The advancement of immuno-PET into clinical useBrian D Wright, Suzanne E LapiNuclear Medicine and Biology|January 21, 2012
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35 years of the ISRC?Suzanne E Lapi, Michael J WelchNuclear Medicine and Biology|January 30, 2013
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35years of the ISRC?Suzanne E Lapi, Michael J WelchPageof 17